Toby Ferguson's appointment, with his vast experience in nov...
Toby Ferguson's appointment, with his vast experience in novel therapies, is anticipated to benefit Voyager immediately, particularly as the company prepares to file its first IND with VY-TAU01, an antibody targeting pathological tau in Alzheimer's disease.
Press Release: Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3251Followers
0Following
8012Visitors
Follow